Eidos Therapeutics Inc (OQ:EIDX)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 16/19 Apr 15/19 Fox Jonathan C Indirect Ownership Common Stock S - Open market or private sale -5,000 $23.11
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,662  
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,871  
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Common Stock S - Open market or private sale -11,913 $19.66
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 34,662 $0.590
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,871 $0.150
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 2,664 $13.96
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 37,989 $13.29
Feb 14/19 Dec 10/18 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 2,664 $13.96
Feb 14/19 Dec 10/18 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 37,989 $13.29
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 16/19 Apr 15/19 Fox Jonathan C Indirect Ownership Common Stock S - Open market or private sale -5,000 $23.11
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,662  
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,871  
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Common Stock S - Open market or private sale -11,913 $19.66
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 34,662 $0.590
Mar 21/19 Mar 19/19 Siu Christine Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,871 $0.150
Mar 21/19 Nov 30/18 Siu Christine Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,081 $12.01
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 2,664 $13.96
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 37,989 $13.29
Feb 14/19 Dec 7/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 4,860 $14.36
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $EIDX

  • No tweets found

StockTwits